ACQUINET
LIVE

Serial Number

99106752

Owner

Insightec Ltd.

Attorney

Julia Anne Matheson

Filing Date

Mar 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ACQUINET Trademark

Serial Number: 99106752

ACQUINET is a trademark filed by Insightec Ltd. on March 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Insightec Ltd. (14 trademarks)

5 Nachum Heth Street
Tirat Carmel 3912001 , IL

Entity Type: 03

Trademark Details

Filing Date

March 27, 2025

Registration Date

Not Registered

Published for Opposition

October 21, 2025

Goods & Services

Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to facilitate the lowering of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to facilitate the disruption of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to increase the permeability of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures in the fields of neurology, oncology, gynecology and urology; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures with respect to central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures, namely, for use in the ablation of tissue, sonication of tissue, and disruption of the blood brain barrier

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 21, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 21, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 21, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 21, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 16, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 24, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 24, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 24, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 24, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 26, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 26, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 26, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 27, 2025 MAFR
NEW APPLICATION ENTERED
Mar 27, 2025 NWAP